Development of a high affinity and stereoselective photoaffinity label for the D-1 dopamine receptor: Synthesis and resolution of 7-[ 125I]iodo-8-hydroxy-3-methyl-1-(4′-azidophenyl)-2,3,4,5- tetrahydro-1H-3-benzazepine (original) (raw)

Journal of Medicinal Chemistry

In an earlier paper, we reported the development of (*)-7-iodo-8-hydroxy-3-methyl-l-(4'-azidophenyl)-2,3,4,5tetrahydro-1H-3-benzazepine (I-MAB) and its '%I analogue ([ '%I]I-MAB) as selective, high affinity photoaffinity labels for the D-1 dopamine receptor. In this report, we now describe the complete synthesis and resolution of I-MAB and the pharmacological characterization of the stereoisomers in canine striatal membranes. R-(+)-I-MAB showed highly specific dopamine D-1 receptor binding (KD = 0.28 nM) and binds selectively and stereoselectively to the D-1 receptor. These results further confirm the previous suggestion that, in the benzazepine series of DA agonists and antagonists, the activity principally resides in the I?-(+) enantiomer, the S-(-) enantiomer being considerably less potent or inactive. Moreover, R-(+)-[12SI]I-MAB, upon photolysis, identifies the ligand-binding subunits of the neuronal D-1 receptor, with an apparent M , of 74 OOO, 62 OOO, and 51 OOO as assessed by autoradiography following sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Photoincorporation of R-( +)-[12SI]I-MAB into these polypeptides was stereoselectively blocked by D-1 dopaminergic ligands with an appropriate pharmacologic profile for the receptor. R-(+)-[12SI]I-MAB should thus prove to be a useful stereoselective photoaffiiity label for the further characterization of the D-1 receptors. (3) Calne, D. B.; Larsen, T.